Adaptimmune Therapeutics plc American Depositary Shares (ADAP) Return on Equity (ROE) (2015 - 2025)
Adaptimmune Therapeutics plc American Depositary Shares (ADAP) Return on Equity (ROE) from Jun 30, 2015 to Jun 30, 2025. The TTM Adaptimmune Therapeutics plc American Depositary Shares (ADAP) Return on Equity (ROE) is 42.76%. You can export chart.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of Adaptimmune Therapeutics plc American Depositary Shares (ADAP)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2024 | -597.55% | +107.34% |
| 2023 | -288.21% | +42.62% |
| 2022 | -202.08% | +163.27% |
| 2021 | -76.76% | +101.34% |
| 2020 | -38.12% | -65.63% |
| 2019 | -110.93% | +186.76% |
| 2018 | -38.69% | +11.95% |
| 2017 | -34.56% | -19.80% |
| 2016 | -43.08% | N/A |